NICA — Nanologica AB (publ) Income Statement
0.000.00%
Last trade - 00:00- SEK92.78m
- SEK71.67m
- SEK14.54m
Annual income statement for Nanologica AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 16.1 | 12.9 | 1.55 | 1.44 | 14.5 |
| Cost of Revenue | |||||
| Gross Profit | 15 | 4.92 | 3.23 | -0.076 | 4.29 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 35.7 | 53.6 | 52.4 | 71.4 | 73.8 |
| Operating Profit | -19.6 | -40.7 | -50.9 | -70 | -59.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -22.2 | -44.8 | -55.2 | -75.2 | -65.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -22.2 | -44.8 | -55.2 | -75.2 | -65.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -22.2 | -44.8 | -55.2 | -75.2 | -65.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -22.2 | -44.8 | -55.2 | -75.2 | -65.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.888 | -1.53 | -1.74 | -1.72 | -1.21 |
| Dividends per Share |